内容摘要：Nor could that kind of study be accomplished quickly enough to get millions of people vaccinated before the yearly winter surge, said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

Nor could that kind of study be accomplished quickly enough to get millions of people vaccinated before the yearly winter surge, said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

“Many of our customers were friends of the farmers. That is where the problem originated from,” said Tendai Gwaravaza, chairman of Chitungwiza Arts Center.At the center, the sound of grinders filled the air as sculptors carved. Hundreds of finished pieces, ranging from small carvings to life-sized sculptures, waited for buyers.

“The only solution now is to get out there to the markets ourselves. If we don’t, no one will,” Gwaravaza said.The Oxford exhibition represents such an opportunity for exposure, he said.It is the brainchild of the Oxford Zimbabwe Arts Partnership, formed in response to the “Rhodes Must Fall” campaign during the

protests in the U.S.The group, consisting of Zimbabwean artists, an Oxford alumnus and a professor of African history, initially envisioned a larger project titled “Oxford and Rhodes: Past, Present, and Future.” It included enclosing Rhodes’ statue in glass, installing 100 life-size bronze statues of African liberation fighters and creating a collaborative sculpture using recycled materials to represent the future.

However, the project required an estimated 200,000 pounds, far beyond available resources. Eventually, Oriel College provided 10,000 pounds for a scaled-down exhibition.

“It’s still my hope that one day it could happen, but for now we have just accepted something very small to make a start and to do something,” said Richard Pantlin, the Oxford alumnus and OZAP co-founder.Doctors said Andrews’ pig kidney turned pink and quickly began producing urine in the operating room, and since then has cleared waste normally with no signs of rejection. Andrews spent the week after his discharge in a nearby Boston hotel for daily checkups but is expected to return home to New Hampshire soon.

NYU transplant surgeon Dr. Robert Montgomery said patients like those in Mass General’s pilot study could be “the sweet spot” for early xenotransplants — not yet too sick from years of dialysis but unlikely to survive long enough for a human transplant.“Those are the patients where it really makes sense for them to try something else,” said Montgomery. His hospital is one of two that will be part of United Therapeutics’ clinical trial later this year, which will include similar patients.

It’s too early to know how Andrews will fare but if the pig kidney were to fail, Riella said he’d still qualify for a human transplant and, now deemed inactive on the transplant list, wouldn’t lose his “waiting time” that helps determine priority.Andrews now wants to return to his old dialysis clinic and “tell these people there’s hope, because no hope is not a good thing,” he said.